Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. S-1MEF Other S-1MEF
  13. S-8 Other Securities Offered to Employees in Benefit Plans
  14. CERT Other Certification
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. S-1/A Offering Registration Statement
  17. 8-A12B Other Registration of Securities
  18. UPLOAD Other SEC-generated Letter
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 23 of 24 · 471 filings